Social/collaboration Sample Clauses

Social/collaboration. The collaboration suite is part of the Smart vortex suite, as collaboration components interact with components that handle data streams of equipment, for example. The collaboration suite is a software platform that supports real-time collaboration across a multi-organization environment. The platform supports its users through many types of (synchronous) collaboration components, such as: video-conferencing, discussion and data analysers. The social collaboration component supports these components by providing expert finding functionalities. Through this component, a group can search and invite experts according to their skills and expertise. The core of the social collaboration suite is used for routing requests between organizations. This can be used by other components of the SMART VORTEX suite. For this mechanism to work, the partners need to specify whether the data needs to be mapped between instances. Synchronous collaboration services and access control Initiation of synchronous collaboration session is typically done by the Session Initiation Protocol (SIP). When access control is required (e.g. inter-organizational collaborative work), access control based on a challenge/response security mechanisms is supported in the SIP INVITE process. The SIP-based authentication / authorization can be regarded as a PEP in the XACML based access control architecture. The PDP will be in the SIP proxy server. In the overall framework, a mapping will be necessary from the credentials used to identify a Smart Vortex user to a SIP address used in the set-up of synchronous sessions. This could for instance be done in an LDAP directory service, or, more generally, be represented in the collaboration ontology. The SIP proxy servers must be able to access the credentials of all Smart Vortex users that be allowed to set up a (secure) collaboration session.
Sample 1
AutoNDA by SimpleDocs

Related to Social/collaboration

  • AREAS OF COLLABORATION The School will collaborate under Xxxx Innovation Mission to establish, operate and support ATL in India within the school premises with financial support from NITI Aayog.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • For clarity the time allowances provided in clause 2.10 shall operate to reduce the maximum timetabled classroom teaching time specified in clause 4.2 of this agreement.

  • Tax Examinations Abroad 1. A Contracting Party may allow representatives of the competent authority of the other Contracting Party to enter the territory of the first-mentioned Party to interview individuals and examine records with the written consent of the persons concerned. The competent authority of the second-mentioned Party shall notify the competent authority of the first-mentioned Party of the time and place of the meeting with the individuals concerned.

  • PRINCIPLES OF COLLABORATION The parties agree to adopt the following principles when carrying out the Project (Principles):

  • Multi-year Planning Targets Schedule A may reflect an allocation for the first Funding Year of this Agreement as well as planning targets for up to two additional years, consistent with the term of this Agreement. In such an event, the HSP acknowledges that if it is provided with planning targets, these targets:

  • Termination and Return of Materials Within five (5) days of the end of the term of this Agreement or receipt of notice of termination by the MLS, the Receiving Party will return to the MLS all Confidential Information and all other materials provided by the MLS to the Receiving Party. The Receiving Party will also erase, delete, or destroy any Confidential Information stored on magnetic media on other computer storage, including system backups. Upon the request of the MLS, an officer of the Receiving Party will certify in writing that all materials have been returned to the MLS and all magnetic or computer data has been destroyed.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Particular Methods of Procurement of Goods and Works International Competitive Bidding. Goods and works shall be procured under contracts awarded on the basis of International Competitive Bidding.

  • Performance indicators and targets The purpose of the innovation performance indicators and targets is to assist the University and the Commonwealth in monitoring the University's progress against the Commonwealth's objectives and the University's strategies for innovation. The University will report principal performance information and aim to meet the innovation performance indicators and targets set out in the following tables.

Time is Money Join Law Insider Premium to draft better contracts faster.